Carmell Corp (CTCX): Rega marang dodolan

Logo korporat perusahaan Carmell Corp (CTCX)

Carmell Corporation develops bioactive plasma materials to accelerate tissue healing by integrating its regenerative ecosystem into surgical practice. The market capitalization-to-revenue ratio on the GURU.Markets chart visualizes this potential, where 1.60 shapes the current metric. High scientific authority and investor confidence reinforce the professional brand image of CTCX.

Carmell - Multiplikator P/S CTCX (periode 05.04.2024 - 31.12.2024)

Rincian metrik lan analitis perusahaan carmellrx.com (CTCX)

- rega saiki lan proyeksi nilai saham:
Analisis umum perusahaan:CTCX (Carmell)
Barang utama Carmell Corporation

The scale of Carmell Corporation (CTCX) operations in the field of regenerative medicine is assessed via the price-to-sales ratio, which compares market capitalization to annual sales volume. This metric determines the cost of each dollar of revenue, allowing investors to evaluate business sustainability considering patent protection and high profitability, which minimizes the risk of overpaying for future growth.

Perusahaan pesaing

Rasio rega marang pendapatan ASND (Ascendis Pharma AS)|Rasio rega marang pendapatan madrigalpharma.com MDGL|Corcept Therapeutics Corp (CORT) - Rega marang dodolan|RYTM - Rasio rega marang pendapatan|AKRO: Rasio rega marang pendapatan|MTSR: Multiplikator P/S|MLTX - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Crinetics Corp|NewAmsterdam Pharma Corp (NAMS) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan soleno.life (SLNO)|Kapitalisasi marang pendapatan Amicus Therapeutics FOLD|Rasio kapitalisasi pasar marang pendapatan 89bio Inc|Multiplikator P/S Agios Pharmaceuticals, Inc. AGIO|GPCR: Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan MiMedx Corp MDXG|RZLT (Rezolute Corp) - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang pendapatan LXRX|MBX (MBX Biosciences) - Multiplikator P/S|Kapitalisasi marang pendapatan Altimmune Inc (ALT)|Kapitalisasi marang pendapatan AARD (Aardvark Therapeutics Corp)|Kapitalisasi marang pendapatan Sagimet SGMT|Multiplikator P/S BIOA (BioAge Labs)|Multiplikator P/S Biomea Fusion BMEA|QNCX: Kapitalisasi marang pendapatan|GUTS: Rasio rega marang pendapatan|vTv Therapeutics Inc (VTVT) - Rasio rega marang pendapatan|ATPC: Kapitalisasi marang volume dodolan|PLUR (pluri-biotech.com) - Multiplikator P/S|SYBX: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S LPCN|Koefisien rega marang pendapatan Matinas BioPharma Holdings, Inc.|Rasio rega marang pendapatan Spruce Biosciences Inc. SPRB|GLTO - Kapitalisasi marang pendapatan|Lumos Therapeutics - Multiplikator P/S|ONVO: Rasio rega marang pendapatan|Radius Recycling (RDUS) - Rasio rega marang pendapatan